HRP940305A2 - Compositions in the form of solid solutions - Google Patents

Compositions in the form of solid solutions Download PDF

Info

Publication number
HRP940305A2
HRP940305A2 HRP4316537.0A HRP940305A HRP940305A2 HR P940305 A2 HRP940305 A2 HR P940305A2 HR P940305 A HRP940305 A HR P940305A HR P940305 A2 HRP940305 A2 HR P940305A2
Authority
HR
Croatia
Prior art keywords
weight
preparations
coumarin
polymer
contain
Prior art date
Application number
HRP4316537.0A
Other languages
English (en)
Croatian (hr)
Inventor
Sven Grabowski
Winfried Mueller
Joerg Rosenberg
Rudolf Binder
Axel Sanner
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HRP940305A2 publication Critical patent/HRP940305A2/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HRP4316537.0A 1993-05-18 1994-05-17 Compositions in the form of solid solutions HRP940305A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4316537A DE4316537A1 (de) 1993-05-18 1993-05-18 Zubereitungen in Form fester Lösungen

Publications (1)

Publication Number Publication Date
HRP940305A2 true HRP940305A2 (en) 1996-12-31

Family

ID=6488330

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP4316537.0A HRP940305A2 (en) 1993-05-18 1994-05-17 Compositions in the form of solid solutions

Country Status (23)

Country Link
US (1) US5684040A (da)
EP (1) EP0697867B1 (da)
JP (1) JPH08510219A (da)
KR (1) KR960702305A (da)
CN (1) CN1123524A (da)
AT (1) ATE209913T1 (da)
AU (1) AU688328B2 (da)
BR (1) BR9406414A (da)
CA (1) CA2163255A1 (da)
CZ (1) CZ300895A3 (da)
DE (2) DE4316537A1 (da)
DK (1) DK0697867T3 (da)
ES (1) ES2169073T3 (da)
FI (1) FI955524A0 (da)
HR (1) HRP940305A2 (da)
HU (1) HUT73657A (da)
IL (1) IL109532A (da)
NO (1) NO954660D0 (da)
NZ (1) NZ267080A (da)
PL (1) PL311698A1 (da)
SI (1) SI9420035A (da)
WO (1) WO1994026267A1 (da)
ZA (1) ZA943368B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE60143704D1 (de) * 2000-09-25 2011-02-03 Nippon Shinyaku Co Ltd Verfahren zur herstellung einer medizinischen festen dispersion
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
WO2003000292A1 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers
MXPA03011935A (es) * 2001-06-22 2004-03-26 Pfizer Prod Inc Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco.
US20040015519A1 (en) * 2001-10-15 2004-01-22 Yukitoshi Maeda Content delivery server and content delivery system having the same
PL371416A1 (en) 2002-02-01 2005-06-13 Pfizer Products Inc. Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
AU2003249474A1 (en) 2002-08-12 2004-02-25 Pfizer Products Inc. Pharmaceutical compositions of semi-ordered drugs and polymers
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
WO2005005401A1 (ja) * 2003-07-11 2005-01-20 Osaka Industrial Promotion Organization スルホン酸エステル化合物およびそれを用いた蛍光プローブ
EP1650200A4 (en) * 2003-07-11 2008-03-19 Osaka Ind Promotion Org SULPHONATE COMPOUND AND FLUORESCENCE ENCODER USING THIS
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS5446837A (en) * 1977-09-19 1979-04-13 Kanebo Ltd Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same
BE880713A (fr) * 1978-12-21 1980-06-19 Sandoz Sa Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
DE3243158A1 (de) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンa物質含有易溶性固形製剤
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
JP2636265B2 (ja) * 1987-10-06 1997-07-30 萬有製薬株式会社 脳循環改善剤
DE3830355A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur herstellung von pharmazeutischen tabletten
DE3834860A1 (de) * 1988-10-13 1990-04-19 Basf Ag Heterocyclisch substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Also Published As

Publication number Publication date
DE4316537A1 (de) 1994-11-24
AU688328B2 (en) 1998-03-12
CA2163255A1 (en) 1994-11-24
NZ267080A (en) 1996-11-26
EP0697867A1 (de) 1996-02-28
FI955524A7 (fi) 1995-11-16
DE59409994D1 (de) 2002-01-17
JPH08510219A (ja) 1996-10-29
FI955524L (fi) 1995-11-16
FI955524A0 (fi) 1995-11-16
EP0697867B1 (de) 2001-12-05
PL311698A1 (en) 1996-03-04
NO954660L (no) 1995-11-17
HU9503296D0 (en) 1996-01-29
IL109532A (en) 1997-11-20
ZA943368B (en) 1995-11-17
WO1994026267A1 (de) 1994-11-24
AU6926394A (en) 1994-12-12
CN1123524A (zh) 1996-05-29
SI9420035A (en) 1996-06-30
KR960702305A (ko) 1996-04-27
DK0697867T3 (da) 2002-03-11
HUT73657A (en) 1996-09-30
CZ300895A3 (en) 1996-02-14
US5684040A (en) 1997-11-04
IL109532A0 (en) 1994-08-26
ES2169073T3 (es) 2002-07-01
BR9406414A (pt) 1995-12-19
NO954660D0 (no) 1995-11-17
ATE209913T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
KR101156916B1 (ko) 이마티닙 및 방출 지연제를 포함하는 제약 조성물
AU2007301742B2 (en) Pharmaceutical compositions of aripiprazole
AU2007316558A1 (en) Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
PT1753406E (pt) Formulação e método para comprimidos revestidos
KR20150082203A (ko) 엔잘루타마이드 제제
JPH02104A (ja) 薬物放出速度調節型製剤
EP3501506A1 (en) Pharmaceutical tablet composition comprising brexpiprazole
US5684040A (en) Compositions in the form of solid solutions
TW201526921A (zh) 一種替格瑞洛固體分散體及其製備方法
KR20180021814A (ko) 약물을 포함하는 속방성 정제 및 상기 정제의 형성 공정
KR20260029301A (ko) 골수성 키놈 억제제의 고체 분산물 및 그를 포함하는 제약 조성물
EA031607B1 (ru) Фармацевтическая композиция
KR101503083B1 (ko) 고형 제제의 제조 방법
Dos Santos et al. Eudragit®: A Versatile Family of Polymers for Hot Melt Extrusion and 3D Printing Processes in Pharmaceutics. Pharmaceutics 2021, 13, 1424
NZ223228A (en) Lactone derivatives as carriers in controlled and delayed release oral pharmaceutical compositions
CZ298604B6 (cs) Farmaceutická smes v pevné forme vhodné pro tabletování a obsahující profen
CN105726499B (zh) 一种利伐沙班药物组合物及其制备方法
EP4385497A1 (en) Antioxidant-free fixed dose combination of netupitant and palonosetron
EP4385500A1 (en) Fixed dose combination comprising netupitant and palonosetron
ES2586912T3 (es) Forma de dosificación que comprende lopinavir no cristalino y ritonavir cristalino
WO2024126408A1 (en) Antioxidant-free fixed dose combination of netupitant and palonosetron
KR101741414B1 (ko) 크리소스플레놀 c 함유 고체 분산체, 이를 포함하는 약제학적 조성물 및 이의 제조방법
WO2024126398A1 (en) Fixed dose combination comprising netupitant and palonosetron
WO2010082855A1 (en) Pharmaceutical compositions comprising ziprasidone free base or ziprasidone hydrochloride and the method for their preparation
Onunkwo et al. Mechanisms of Drug Release from Theophylline Monohydrate Sustained Release Tablet Matrices formulated with Okro Gum

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODBC Application rejected